INTERVIEW

PRIME NEXUS: Advancing the Autoinjector with the Power of Software

In this exclusive interview, Dr Patrick Anquetil sits down with Guy Furness to talk about how Portal and the drug delivery industry have changed since the company was first founded over a decade ago and the significant unmet need in injectable drug delivery around the 5–10 mL volume range. Dr Anquetil explains how Portal’s electromechanical PRIME NEXUS platform uses software to solve challenges in this space that springs simply cannot, and how devices such as PRIME NEXUS are set to meet the expectations of the future.

Interview: Contamination Control in Practice: BD’s Global, Risk-Based Approach to Supporting Sterile Drug Manufacturing

BD's Patrick Jeukenne and Frédérique Pedretti-Abel explain how the company is putting contamination control into practice through global strategy, concrete investments and measurable actions. This approach is designed to support pharmaceutical manufacturers’ compliance and operational performance, while ultimately contributing to the quality and safety of medicines delivered to patients.

When More Matters – Advancing Large-Volume Drug Delivery with SHL’s Magnitude

Vince Masciopinto

When More Matters – Advancing Large-Volume Drug Delivery with SHL’s Magnitude

In this interview, Vince Masciopinto, discusses the strategic evolution of SHL's Maggie platform into Magnitude while discussing large-volume delivery and considering the technical breakthroughs, market shifts and user insights that define its growth.

Interview: Eco-Inject: Bringing Affordable Sustainability to Single-Use Disposable Autoinjectors

Interview: Eco-Inject: Bringing Affordable Sustainability to Single-Use Disposable Autoinjectors

In this exclusive interview, Michael Earl and Steven Kaufman speak about the significant progress Eco-Inject has made throughout 2026 since its highly successful funding round earlier in the year, discussing what’s new in the world of Eco-Inject, what sets the device platform apart from other approaches to sustainability in the autoinjector space, and how the industry is reacting to Eco-Inject as it moves towards the market.

Interview: Rethinking Drug Delivery for Increasingly Complex Therapies

Interview: Rethinking Drug Delivery for Increasingly Complex Therapies

In this interview, Ram Halthore discusses the demands of newer classes of injectable drugs and the trend towards self-administration using conventional drug delivery systems, the requirements innovative systems must meet and the importance of selecting a delivery system early in formulation development, as well as the roles that robust human factors engineering and high reliability should play in device development.

Off The Critical Path: Bringing Device Strategy Forward In Combination Product Development

Ventura Solutions

Off The Critical Path: Bringing Device Strategy Forward In Combination Product Development

David Karvani and Greg Moakes discuss how early collaboration with device development partners can help pharma companies navigate the technical and regulatory complexities of combination product development.

Interview: Celebrating 10 Years of Molly Enabling Patients’ Independence

Nicholas Heaton

Interview: Celebrating 10 Years of Molly Enabling Patients’ Independence

Nicholas Heaton looks back on the decade since Molly – SHL Medical’s signature two-step autoinjector platform – was launched onto the market, reviewing what made the device platform a success, where Molly is positioned in the market today and how it will continue to evolve to meet the demands of the future.

Interview: GLP-1 Demand and the New Reality of Device Manufacturing Capacity

Interview: GLP-1 Demand and the New Reality of Device Manufacturing Capacity

Andy Wertheim discusses the growing shortage of available manufacturing capacity driven by the boom in GLP-1 therapies, why this means mid-volume development programmes across a range of sectors are struggling to move from development to industrialisation, and how Quvara Medical is ideally positioned to provide the capacity that these programmes lack.

Exclusive Interview: Taking Sustainability Beyond Compliance

Prof Hanns-Christian Mahler

Exclusive Interview: Taking Sustainability Beyond Compliance

Prof Hanns-Christian Mahler engages in a wide-ranging discussion about current challenges and trends in the drug delivery industry, particularly on the topic of sustainability – it’s advantages, difficulties and why companies should aim to do more than the bare minimum required by the regulation.

Interview: Inside The Crux Technology Centre

INDUSTRIALISATION

Stephen Gilmore

Crux Product Design

Interview: Inside The Crux Technology Centre

Stephen Gilmore discusses the opportunities and capabilities unlocked by Crux’s new Technology Centre located in Bristol, UK. Mr Gilmore provides an overview of the new capabilities provided by the facility and the potential it represents to the future of the company.

Sustainable Packaging and Patient-Centric Design

Cambridge Design Partnership

Sustainable Packaging and Patient-Centric Design

Steve Augustyn and Jon Powell discuss a range of key topics in the drug delivery industry, including design complexity, sustainable materials and patient-centric design.

Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta

Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta

Bart Burgess discusses some of the key areas for innovation in the industry, such as rare diseases and moving away from variable dosing solutions, and introduces Quanta – SHL's latest product offering.

Automated Testing to Decrease Time-To-Market

Landon Goldfarb

Automated Testing to Decrease Time-To-Market

Landon Goldfarb highlights the advantages conferred by Instron's Cobot automated testing system at both the design verification and production stages of autoinjector development.

Sustainability, Balancing Priorities, and Bringing New Solutions to Market

Sustainability, Balancing Priorities, and Bringing New Solutions to Market

Steven Kaufman discusses the return of sustainability to the centre of drug delivery conversation and how Eco-Inject's novel autoinjector brings fresh thinking to the sector.

Dual-Chamber Syringes, New Partnerships, and Speed-to-Market Pressures Shape 2026

Credence MedSystems

Dual-Chamber Syringes, New Partnerships, and Speed-to-Market Pressures Shape 2026

John Merhige outlines his key themes shaping drug delivery in 2026: new momentum from a dual-chamber syringe fill-finish collaboration, a newly announced commercial supply agreement with a major global pharma company, and growing pressure to deliver increasingly complex molecules faster and more efficiently.

Challenges, Trends, and Recognising Innovation

Laura Armstrong

Challenges, Trends, and Recognising Innovation

Laura Armstrong discusses the challenges and trends currently impacting the drug delivery and pharmaceutical packaging industry.

Interview: Enhancing Clinical Trials with CliniPilot<sup>®</sup> and Clear to Clinic™ Programme

Dr Carolina Canapè

Interview: Enhancing Clinical Trials with CliniPilot^® and Clear to Clinic™ Programme

Dr Carolina Canapè and Roger Lüscher talk with Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors support faster, more efficient and more effective clinical trials.

Interview: Developing Wearable Injectors

EdgeOne Medical

Interview: Developing Wearable Injectors

Liat Shochat discusses her extensive experience in wearable drug delivery device development, covering the various challenges that arise from the inherent complexity of these devices, even with multiple successful wearable devices on the market, as well as the best way to engage with contract development organisations such as EdgeOne Medical.

Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise

Dr Aurelie Rebuffet

BD (Becton Dickinson & Company)

Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise

Dr Aurélie Rebuffet and Virginie Jeymond, discuss the new requirements set out in the US Pharmacopeia (USP) Chapter <382>, including the shift towards assessing the drug-device combination product as a holistic whole and how ZebraSci and BD can support pharma companies in complying with USP <382>.

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Daré Bioscience

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Liz Proos and Ashley Hawson talk exclusively with ONdrugDelivery's Guy Furness about the DARE Intelligent Drug Delivery System – an advanced, connected implantable device that delivers programmable doses for up to a decade – its place in the market, the challenges faced during its design and its potential as novel drug delivery device.

Interview: Aptar Pharma Expansion With New R&D Center

Christophe Pierre

Interview: Aptar Pharma Expansion With New R&D Center

In this interview, Christophe Pierre introduces Aptar Pharma’s new R&D Center in France, and outlines how the new facility will assist the development of smarter, more integrated drug delivery solutions, facilitating progression from concept to full-scale industrialisation across multiple therapeutic fields.

Interview: Integrating Phillips Medisize and Vectura’s Operations

Charlie Schumacher

Phillips Medisize

Interview: Integrating Phillips Medisize and Vectura’s Operations

In this interview, Charlie Schumacher and Sandy Munro discuss Phillips Medisize’s progress on its integration of Vectura, covering aspects such as cultural alignment, technical innovation and the evolving role of CDMOs in the inhalation landscape.

Interview: A Structured Approach to the Eco-Design Process

Fabien de Coninck

Interview: A Structured Approach to the Eco-Design Process

Fabien De Coninck and Bruno Morchain discuss Aptar Pharma’s eco-design philosophy with ONdrugDelivery’s Guy Furness. They cover how Aptar Pharma has implemented lifecycle assessments as a key tool to elucidate the environmental footprint of the company’s rubber components for primary packaging for injectable systems, including how they tackled the unique challenges presented by the complex, proprietary formulations involved in elastomer component design.

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Portal Instruments

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Steven Kaufman talks with ONdrugDelivery’s Guy Furness about the world of autoinjectors, looking at the current status quo in the industry, using Portal’s PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.

Interview: Making Dual-Chamber Systems a Viable Alternative

Laxman Halleppanavar

Credence MedSystems

Interview: Making Dual-Chamber Systems a Viable Alternative

In this exclusive interview, Laxman Halleppanavar and Guy Furness discuss industry trends and challenges with injectable delivery, and how Credence MedSystems' dual-chamber devices provide solutions to address those challenges. Mr Halleppanavar goes into details of Credence’s role in this increasingly important sector of the drug delivery market, explaining the company’s approach to device design, development and overcoming the barriers posed by supply chain management.

Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group

Gilbert Fluetsch

Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group

Gilbert Fluetsch discusses the establishment of SHL Advantec and the foundation it has built as SHL Medical’s in-house equipment specialist. Mr Fluetsch also looks at the role of modular platforms in scaling production and how the company’s global network is designed to support the changing landscape of medical and pharma manufacturing.

1
2
3
…
6
Next

Top